Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and On...
GRAIL, Inc. (GRAL)
Company Research
Source: Yahoo! Finance
non-invasive diagnosis, driven by rising cancer cases and precision oncology trends. Advancements in multi-cancer assays, minimal residual disease detection, and decentralized platforms enhance clinical application, supporting widespread adoption in diagnostics. Liquid Biopsy For Early Cancer Detection And Monitoring Market Liquid Biopsy For Early Cancer Detection And Monitoring Market Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy For Early Cancer Detection And Monitoring Market Size, Share & Trends Analysis Report By Biomarker (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)), By Technology, By Cancer, By End Use, By Region, And Segment Forecasts, 2025 - 2033" report has been added to ResearchAndMarkets.com's offering. The global liquid biopsy for early cancer detection and monitoring market size was estimated at USD 2.23 billion in 2024 and is projected to reach USD 6.20 billion by 2033, growing at a CAGR of 12.14% from 2025 to 2033. This market
Show less
Read more
Impact Snapshot
Event Time:
GRAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRAL alerts
High impacting GRAIL, Inc. news events
Weekly update
A roundup of the hottest topics
GRAL
News
- GRAIL (NASDAQ:GRAL) was given a new $110.00 price target on by analysts at Morgan Stanley.MarketBeat
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- GRAIL to Present at Piper Sandler 37th Annual Healthcare ConferencePR Newswire
- GRAIL (NASDAQ:GRAL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $85.00 to $105.00. They now have a "buy" rating on the stock.MarketBeat
- Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold [Seeking Alpha]Seeking Alpha